author-photo

William Reiss

Genentech

22

Papers

677

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

THU0177 DURABILITY OF RESPONSE AMONG PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING TOCILIZUMAB: DATA FROM THE US-BASED CORRONA RHEUMATOID ARTHRITIS REGISTRY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis.

2020 American health & drug benefits
Show All
- Source
- Cite
- Save
Citations (0)
Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (16)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (443)
MRI Results Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy

2019 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (2)
Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab

2018 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (32)
SAT0168 Mri results following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab: Predicting Future Good Radiographic and Functional Outcomes

2017 Arthritis Care and Research
Show All
- Source
- Cite
- Save
Citations (10)
FRI0222 Sustained response following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial (COMP-ACT)

2017 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (3)
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

2016 Rheumatology International
Show All
- Source
- Cite
- Save
Citations (15)